Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection

Cancer Prevention Research

Volumn 7, Issue 5, 2014, Pages 526-533

  Brandsma, Janet L ^a   Harigopal, Malini ^a   Kiviat, Nancy B ^c   Sun, Ying ^a   Deng, Yanhong ^b   Zelterman, Daniel ^a   Lizardi, Paul M ^a   Shabanova, Veronika S ^b   Levi, Angelique ^a   Yaping, Tian ^a   Hu, Xinyuan ^a   Feng, Qinghua ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; CPG ISLAND; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DISEASE SEVERITY; DNA METHYLATION; DNA SEQUENCE; EMERGENCY HEALTH SERVICE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; TUMOR INVASION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; CERVICAL INTRAEPITHELIAL NEOPLASIA; GENETICS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; VIROLOGY; YOUNG ADULT;

TUMOR MARKER; VIRUS DNA;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CPG ISLANDS; DNA METHYLATION; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TRIAGE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84900815448     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0354     Document Type: Article

References (53)

1. Astbury K, Turner MJ. Human papillomavirus vaccination in the prevention of cervical neoplasia. Int J Gynecol Cancer 2009;19:1610-3.
2. Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 2007;298:743-53. (Pubitemid 47263157)
3. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533-6.
4. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.
5. Joste NE, Rushing L, Granados R, Zitz JC, Genest DR, Crum CP, et al. Bethesda classification of cervicovaginal smears: reproducibility and viral correlates. Hum Pathol 1996;27:581-5. (Pubitemid 26187282)
6. Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol 1999;42:206-20. (Pubitemid 30017289)
7. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-57.
8. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.
9. Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009;113:18-25.
10. Moscicki A-B, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 2010;116:1373-80.
11. Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 2004;91:942-53. (Pubitemid 39273789)
12. Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 2006;7:547-55. (Pubitemid 43923665)
13. Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee S-K, Kuypers JM, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005;191:731-8. (Pubitemid 40271061)
14. Guedes AC, Zeferino LC, Syrjanen KJ, Brenna SMF. Short-term outcome of cervical intraepithelial neoplasia grade 2: considerations for management strategies and reproducibility of diagnosis. Anticancer Res 2010;30:2319-23.
15. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:489-98. (Pubitemid 43208905)
16. Plante M, Roy M. Fertility-preserving options for cervical cancer. Oncology (Williston Park) 2006;20:479-88. (Pubitemid 46940181)
17. Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol 2011;6:1083-98.
18. Lorincz AT, Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Castanon A, Fiander A, et al. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology. Int J Cancer 2013;133:637-44.
19. Kiviat NB, Hawes SE, Feng Q. Screening for cervical cancer in the era of the HPV vaccine-the urgent need for both new screening guidelines and new biomarkers. J Natl Cancer Inst 2008;100:290-1. (Pubitemid 351480529)
20. Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LSH, Li BFL, et al. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 2004;324:483-92. (Pubitemid 38797864)
21. Badal V, Chuang LSH, Tan EH-H, Badal S, Villa LL, Wheeler CM, et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 2003;77:6227-34. (Pubitemid 36588393)
22. Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA, Guido-Jimenez MC, Kalantari M, Calleja-Macias IE, et al. Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 2007;120:2165-9. (Pubitemid 46555853)
23. Bhattacharjee B, Sengupta S. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 2006;354:280-5. (Pubitemid 44527961)
24. Chaiwongkot A, Vinokurova S, Pientong C, Ekalaksananan T, Kongyingyoes B, Kleebkaow P, et al. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Int J Cancer 2013;132:2087-94.
25. Feng Q, Hawes SE, Stern JE, Dem A, Sow PS, Dembele B, et al. Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2007;16:1178-84. (Pubitemid 46984956)
26. Henken FE, Wilting SM, Overmeer RM, van Rietschoten JGI, Nygren AOH, Errami A, et al. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 2007;97:1457-64. (Pubitemid 350114795)
27. Kalantari M, Villa LL, Calleja-Macias IE, Bernard H-U. Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int J Cancer 2008;123:1832-40.
28. Rajeevan MS, Swan DC, Duncan K, Lee DR, Limor JR, Unger ER. Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J Virol Methods 2006;138:170-6. (Pubitemid 44633461)
29. Rosl F, Arab A, Klevenz B, zur Hausen H. The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol 1993;74:791-801. (Pubitemid 23154279)
30. Turan T, Kalantari M, Calleja-Macias IE, Cubie HA, Cuschieri K, Villa LL, et al. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology 2006;349:175-83.
31. Wiley DJ, Huh J, Rao JY, Chang C, Goetz M, Poulter M, et al. Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. J Acquir Immune Defic Syndr 2005;39:143-51. (Pubitemid 40741111)
32. Hublarova P, Hrstka R, Rotterova P, Rotter L, Coupkova M, Badal V, et al. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status. Int J Gynecol Cancer 2009;19:321-5.
33. Piyathilake CJ, Macaluso M, Alvarez RD, Chen M, Badiga S, Edberg JC, et al. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer 2011;117:957-63.
34. Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, Haines GKI, et al. Distinct Human Papillomavirus Type 16 Methylomes in Cervical Cells at Different Stages of Premalignancy. Virology 2009;389:100-7.
35. Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, Ropero S, et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 2009;19:438-51.
36. Sun C, Reimers LL, Burk RD. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol 2011;121:59-63.
37. Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, et al. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a costa rican population. J Natl Cancer Inst 2012;104:556-65.
38. Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, et al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer 2013;132:1412-22.
39. Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947;18:50-60.
40. Lehmann E. Nonparametrics: statistical methods based on ranks. Holden Day; 1975.
41. Team RDC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
42. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92. (Pubitemid 23095196)
43. Schiffman M, Rodriguez AC. Heterogeneity in CIN3 diagnosis. Lancet Oncol 2008;9:404-6. (Pubitemid 351618081)
44. McCredie MRE, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34.
45. Vink MA, Bogaards JA, van Kemenade FJ, de Melker HE, Meijer CJ, Berkhof J. Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data. Am J Epidemiol 2013;178:1161-9.
46. Buhmeida A, Merdad A, El-Maghrabi J, Al-Thobaiti F, Ata M, Bugis A, et al. RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency. Anticancer Res 2011;31:2975-81.
47. de Sousa E Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011;9:476-85.
48. Kioulafa M, Balkouranidou I, Sotiropoulou G, Kaklamanis L, Mavroudis D, Georgoulias V, et al. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer. Int J Cancer 2009;125:2887-92.
49. Seng TJ, Currey N, Cooper WA, Lee CS, Chan C, Horvath L, et al. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma. Br J Cancer 2008;99:375-82.
50. Feng S, Rubbi L, Jacobsen SE, Pellegrini M. Determining DNA methylation profiles using sequencing. Methods Mol Biol 2011;733:223-38.
51. Flusberg BA, Webster DR, Lee JH, Travers KJ, Olivares EC, Clark TA, et al. Direct detection of DNA methylation during single-molecule, realtime sequencing. Nat Methods 2010;7:461-5.
52. Sepulveda AR, Jones D, Ogino S, Samowitz W, Gulley ML, Edwards R, et al. CpG methylation analysis-current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. J Mol Diagn 2009;11:266-78.
53. Giannoudis A, Herrington CS. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 2001;193:295-302. (Pubitemid 32229859)